Search results
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 7 hours agoThe company's trials include AVANZAR, evaluating Dato-DXd plus Imfinzi for first-line treatment of...
Pfizer's drug for advanced lung cancer shows promising long-term trial results
CNBC· 5 days agoPfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 1 day agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”
IFLScience· 2 days agoPhase III trial results for a new drug targeting advanced lung cancer have just been reported, with...
SSM Health Medical Minute: Lung cancer screening as critical as mammogram, colonoscopy
KTVI via Yahoo News· 7 days agoLung cancer is the leading cause for cancer-related death in the United States. Screening before...
New pathways for treating never-smoker lung cancer revealed
Medical Xpress· 2 days agoThe primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.
AstraZeneca immunotherapy extends survival by two years in rarer type of lung cancer
BioPharma Dive via Yahoo Finance· 4 days agoAstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live...
Toddler with rare form of cancer surprised with new backyard playset
FOX 8 Cleveland· 57 minutes ago“When you’re in your backyard and you’re swinging and sliding and just having fun, then now you’re...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Landmark Blood-Based AI Lung Cancer Screening Test Study Results Published in Cancer Discovery
Tehachapi News· 2 days agoThe transformative approach to genomic sequencing yields the first validated high-sensitivity lung cancer screening test that could close gaps in screening ...